Skip to main content
. 2015 Oct 13;17(1):120–132. doi: 10.1208/s12249-015-0417-7

Fig. 5.

Fig. 5

FT-Raman spectrum (from bottom to top) of GRIS amorphous drug (Inline graphic), polymer (Inline graphic), HME processed dispersions (Inline graphic), and KSD processed dispersions (Inline graphic) (from 10% to 40% drug load) in a (PVP K17) and c (HPMC E5). KSD processed dispersions of PVPK30 (Inline graphic) and PVP K90 (Inline graphic) (from 10% to 40% drug load) in b, and KSD processed dispersions of HPMC E15 (Inline graphic) and HMPC E50 (Inline graphic) (from 10% to 40% drug load) in d. Features corresponding to crystalline drug are marked with arrows